Processing

Cipla sets up JV in China as ‘crucial’ part of future roadmap

06-Aug-2019 By Ben Hargreaves

Cipla teams up with Acebright to create joint venture, which will involve the building of a manufacturing facility to produce respiratory products.

Acquisition adds European design to ACG’s manufacturing services

06-Aug-2019 By Maggie Lynch

ACG Engineering acquires Xertecs to add European design to its existing Indian engineering and manufacturing capabilities as it globalizes.

Demand for Gardasil leads to $650m investment in Merck’s operations

30-Jul-2019 By Maggie Lynch

Merck to invest in its North Carolina facilities as it expands production capacity to meet demand for its HPV vaccine Gardasil, and grow its packaging operations

Civica signs five-year agreement with Hikma to reduce drug shortages

25-Jul-2019 By Ben Hargreaves

Civica and Hikma agree a manufacture and supply partnership to increase access to 14 essential sterile injectable medicines for the US hospital network.

‘Removing the need for other partners’: Onyx invests in commercial API license

11-Jul-2019 By Maggie Lynch

Onyx invests in a commercial API license and expands its UK facility to bolster its manufacturing capabilities for niche, small-scale production.

Processing seals market accelerated by Industry 4.0

10-Jul-2019 By Ben Hargreaves

The pharmaceutical processing seals market is set to grow by a CAGR of 6% through to 2023, according to a report by TechNavio.

Merck and Biogen both tap Skyhawk’s RNA technology platform

09-Jul-2019 By Maggie Lynch

Skyhawk enters an agreement with Merck to discover and develop small molecules to modulate RNA splicing, and expands its existing development agreement with Biogen.

Ohio facility sees new life as Xellia moves production from North Carolina

02-Jul-2019 By Maggie Lynch

Xellia will move US production from its North Carolina manufacturing facility to its site in Ohio to bolster workforce and manufacture generic IV antibiotics.

Report reveals European country with highest value of production

26-Jun-2019 By Ben Hargreaves

The value generated by the manufacture of medicines has doubled since 2000, with one of the smallest countries in Europe responsible for a significant proportion of the total figure.

AMPAC re-opens 50,000 gallon API facility in Virginia

24-Jun-2019 By Maggie Lynch

After being acquired by SK Holdings, AMPAC re-opens its API manufacturing facility in Virginia as part of a growing investment in its US capabilities.

An ‘immutable record’: Blockchain pilot program to establish security frameworks

18-Jun-2019 By Maggie Lynch

To investigate blockchain processes and make distribution information retrieval more efficient, the FDA tapped big name companies for a supply chain security pilot program.

Boehringer opens €120m facility to meet half of global demand for Respimat

18-Jun-2019 By Ben Hargreaves

Boehringer’s plant opens in Barcelona and will produce 25m units per year of Respimat to be distributed to more than 100 countries.

Lonza’s Swiss site adds HPAPI manufacturing capacity after AZ deal

17-Jun-2019 By Maggie Lynch

Lonza expands its HPAPI production capacity at its Switzerland facility after entering an agreement with AstraZeneca, and invests in manufacturing to establish efficiency.